Table of Contents Author Guidelines Submit a Manuscript

Citations to this Journal [727 citations: 1–100 of 662 articles]

Articles published in Schizophrenia Research and Treatment have been cited 727 times. The following is a list of the 662 articles that have cited the articles published in Schizophrenia Research and Treatment.

  • A. Aparicio, J. L. Santos, E. Jiménez-López, A. Bagney, R. Rodríguez-Jiménez, and E. M. Sánchez-Morla, “Emotion processing and psychosocial functioning in euthymic bipolar disorder,” Acta Psychiatrica Scandinavica, 2017. View at Publisher · View at Google Scholar
  • K. Stegmayer, M. Stettler, W. Strik, A. Federspiel, R. Wiest, S. Bohlhalter, and S. Walther, “Resting state perfusion in the language network is linked to formal thought disorder and poor functional outcome in schizophrenia,” Acta Psychiatrica Scandinavica, 2017. View at Publisher · View at Google Scholar
  • Xue Bai, Chang Liu, Luisa Baladon, and Maria Rubio-Valera, “Multidimensional determinants of the caregiving burden among Chinese male caregivers of older family members in Hong Kong,” Aging & Mental Health, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  • Kensuke Sakamoto, and James J. Crowley, “A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia,” American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2017. View at Publisher · View at Google Scholar
  • Lee-Hou Tsai, “Resolution of antipsychotic-induced amenorrhea using aripiprazole,” Archives of Clinical Psychiatry (São Paulo), vol. 44, no. 4, pp. 111–112, 2017. View at Publisher · View at Google Scholar
  • Vanteemar S Sreeraj, Venkataram Shivakumar, Naren P Rao, and Ganesan Venkatasubramanian, “A Critical Appraisal of Long Acting Injectable Antipsychotics: Translating Research to Clinics,” Asian Journal of Psychiatry, 2017. View at Publisher · View at Google Scholar
  • Chantal Vlaskamp, Bob Oranje, Gitte Falcher Madsen, Jens Richardt Møllegaard Jepsen, Sarah Durston, Cathriona Cantio, Birte Glenthøj, and Niels Bilenberg, “Auditory processing in autism spectrum disorder: Mismatch negativity deficits,” Autism Research, 2017. View at Publisher · View at Google Scholar
  • Mona Buhusi, Daniel Obray, Bret Guercio, Mitchell J. Bartlett, and Catalin V. Buhusi, “Chronic Mild Stress Impairs Latent Inhibition and Induces Region-Specific Neural Activation in CHL1-Deficient Mice, a Mouse Model of Schizophrenia,” Behavioural Brain Research, 2017. View at Publisher · View at Google Scholar
  • Prakash Devaraju, and Stanislav S. Zakharenko, “Mitochondria in complex psychiatric disorders: Lessons from mouse models of 22q11.2 deletion syndrome,” BioEssays, pp. 1600177, 2017. View at Publisher · View at Google Scholar
  • John H. Krystal, Alan Anticevic, Genevieve J. Yang, George Dragoi, Naomi R. Driesen, Xiao-Jing Wang, and John D. Murray, “Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective,” Biological Psychiatry, 2017. View at Publisher · View at Google Scholar
  • Todd A. Tishler, George Bartzokis, Po H. Lu, Erika P. Raven, Mher Khanoyan, Chandra J. Kirkpatrick, Meghan H. Pyle, J. Pablo Villablanca, Lori L. Altshuler, Jim Mintz, Joseph Ventura, Laurie R. Casaus, Kenneth L. Subotnik, Keith H. Nuechterlein, and Benjamin M. Ellingson, “Abnormal Trajectory of Intracortical Myelination in Schizophrenia Implicates White Matter in Disease Pathophysiology and the Therapeutic Mechanism of Action of Antipsychotics,” Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2017. View at Publisher · View at Google Scholar
  • Gina R. Kuperberg, Tali Ditman, and Arim Choi Perrachione, “When proactivity fails: An electrophysiological study of establishing reference in schizophrenia,” Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2017. View at Publisher · View at Google Scholar
  • Víðir Sigrúnarson, Rolf W. Gråwe, Stian Lydersen, and Gunnar Morken, “Predictors of long term use of psychiatric services of patients with recent-onset schizophrenia: 12 years follow-up,” BMC Psychiatry, vol. 17, no. 1, 2017. View at Publisher · View at Google Scholar
  • Michal Arad, Yael Piontkewitz, Noa Albelda, Lee Shaashua, and Ina Weiner, “Immune activation in lactating dams alters sucklings' brain cytokines and produces non-overlapping behavioral deficits in adult female and male offspring: A novel neurodevelopmental model of sex-specific psychopathology,” Brain, Behavior, and Immunity, 2017. View at Publisher · View at Google Scholar
  • Martha S. Windrem, Mikhail Osipovitch, Zhengshan Liu, Janna Bates, Devin Chandler-Militello, Lisa Zou, Jared Munir, Steven Schanz, Katherine McCoy, Robert H. Miller, Su Wang, Maiken Nedergaard, Robert L. Findling, Paul J. Tesar, and Steven A. Goldman, “Human iPSC Glial Mouse Chimeras Reveal Glial Contributions to Schizophrenia,” Cell Stem Cell, 2017. View at Publisher · View at Google Scholar
  • Robin J.M. Franklin, and Edward T. Bullmore, “Do Not Adjust Your Mind: The Fault Is in Your Glia,” Cell Stem Cell, vol. 21, no. 2, pp. 155–156, 2017. View at Publisher · View at Google Scholar
  • Keith Bredemeier, Aaron T. Beck, and Paul M. Grant, “Exploring the Temporal Relationship Between Cognitive Insight and Neurocognition in Schizophrenia: A Prospective Analysis,” Clinical Psychological Science, pp. 216770261773401, 2017. View at Publisher · View at Google Scholar
  • Srihari Gopal, Rosanne Lane, Isaac Nuamah, Margaret Copenhaver, Jaskaran Singh, David Hough, Mark Bach, and Adam Savitz, “Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study,” CNS Drugs, 2017. View at Publisher · View at Google Scholar
  • Steffen Moritz, Mahesh Menon, Devon Andersen, Todd S. Woodward, and Jürgen Gallinat, “Moderators of Symptomatic Outcome in Metacognitive Training for Psychosis (MCT). Who Benefits and Who Does Not?,” Cognitive Therapy and Research, 2017. View at Publisher · View at Google Scholar
  • Fabian Lamster, Tania Lincoln, Clara Nittel, Winfried Rief, and Stephanie Mehl, “The Lonely Road to Paranoia. A Path-Analytic Investigation of Loneliness and Paranoia,” Comprehensive Psychiatry, 2017. View at Publisher · View at Google Scholar
  • Monica S. Wu, Rebecca Hamblin, Joshua Nadeau, Jessica Simmons, Ashley Smith, Meredith Wilson, Stephanie Eken, Brent Small, Vicky Phares, and Eric A. Storch, “Quality of Life and Burden in Caregivers of Youth with Obsessive-Compulsive Disorder Presenting for Intensive Treatment,” Comprehensive Psychiatry, 2017. View at Publisher · View at Google Scholar
  • Anitha Jeyagurunathan, Janhavi Ajit Vaingankar, Edimansyah Abdin, Rajeswari Sambasivam, Lee Seng Esmond Seow, Shirlene Pang, Louisa Picco, Chong Siow Ann, and Mythily Subramaniam, “Gender Differences in Positive Mental Health among Individuals with Schizophrenia,” Comprehensive Psychiatry, 2017. View at Publisher · View at Google Scholar
  • Julia Sevilla Llewellyn-Jones, Pablo Cano Domínguez, Antonia de Luis Matilla, Inmaculada Peñuelas Calvo, Alberto Espina Eizaguirre, Berta Moreno Kustner, and Susana Ochoa, “Personality Traits and Psychotic Symptoms in Recent Onset of Psychosis Patients,” Comprehensive Psychiatry, 2017. View at Publisher · View at Google Scholar
  • Seiya Miyamoto, and W. Wolfgang Fleischhacker, “The Use of Long-Acting Injectable Antipsychotics in Schizophrenia,” Current Treatment Options in Psychiatry, 2017. View at Publisher · View at Google Scholar
  • Mark Savill, Jennifer D'Ambrosio, Tyrone D. Cannon, and Rachel L. Loewy, “Psychosis risk screening in different populations using the Prodromal Questionnaire: A systematic review,” Early Intervention in Psychiatry, 2017. View at Publisher · View at Google Scholar
  • Sami Räsänen, Mika Niemelä, Tanja Nordström, Helinä Hakko, Marianne Haapea, Catherine A Marshall, and Jouko Miettunen, “Parental hospital-treated somatic illnesses and psychosis of the offspring-The Northern Finland Birth Cohort 1986 study,” Early Intervention in Psychiatry, 2017. View at Publisher · View at Google Scholar
  • A.P. Hulkko, G.K. Murray, J. Moilanen, M. Haapea, I. Rannikko, P.B. Jones, J.H. Barnett, S. Huhtaniska, M.K. Isohanni, H. Koponen, E. Jääskeläinen, and J. Miettunen, “Lifetime use of psychiatric medications and cognition at 43 years of age in schizophrenia in the Northern Finland Birth Cohort 1966,” European Psychiatry, 2017. View at Publisher · View at Google Scholar
  • Bettina Lange, Juliane K. Mueller, F. Markus Leweke, and J. Malte Bumb, “How gender affects the pharmacotherapeutic approach to treating psychosis – a systematic review,” Expert Opinion on Pharmacotherapy, pp. 1–12, 2017. View at Publisher · View at Google Scholar
  • Madia Lozupone, Davide Seripa, Eleonora Stella, Maddalena La Montagna, Vincenzo Solfrizzi, Nicola Quaranta, Federica Veneziani, Alberto Cester, Rodolfo Sardone, Caterina Bonfiglio, Gianluigi Giannelli, Paola Bisceglia, Roberto Bringiotti, Antonio Daniele, Antonio Greco, Antonello Bellomo, Giancarlo Logroscino, and Francesco Panza, “Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry,” Expert Review of Proteomics, pp. 1–16, 2017. View at Publisher · View at Google Scholar
  • Claire McGregor, Alexander Riordan, and Janice Thornton, “Estrogens and the cognitive symptoms of schizophrenia: possible neuroprotective mechanisms,” Frontiers in Neuroendocrinology, 2017. View at Publisher · View at Google Scholar
  • Yuta Yoshino, Yuki Ozaki, Kiyohiro Yamazaki, Tomoko Sao, Yoko Mori, Shinichiro Ochi, Jun-ichi Iga, and Shu-ichi Ueno, “DNA Methylation Changes in Intron 1 of Triggering Receptor Expressed on Myeloid Cell 2 in Japanese Schizophrenia Subjects,” Frontiers in Neuroscience, vol. 11, 2017. View at Publisher · View at Google Scholar
  • Sebastiano Alfio Torrisi, Salvatore Salomone, Federica Geraci, Filippo Caraci, Claudio Bucolo, Filippo Drago, and Gian Marco Leggio, “Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D3 Receptor Blockade,” Frontiers in Pharmacology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Marion Leboyer, Pierre Ellul, Laurent Groc, and Ryad Tamouza, “The Clinical Challenge of Autoimmune Psychosis: Learning from Anti-NMDA Receptor Autoantibodies,” Frontiers in Psychiatry, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Laurent Morin, and Nicolas Franck, “Rehabilitation Interventions to Promote Recovery from Schizophrenia: A Systematic Review,” Frontiers in Psychiatry, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Golnoush Alamian, Ana-Sofía Hincapié, Etienne Combrisson, Thomas Thiery, Véronique Martel, Dmitrii Althukov, and Karim Jerbi, “Alterations of Intrinsic Brain Connectivity Patterns in Depression and Bipolar Disorders: A Critical Assessment of Magnetoencephalography-Based Evidence,” Frontiers in Psychiatry, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Nam-Gyoon Kim, and Hakboon Kim, “Schizophrenia: An Impairment in the Capacity to Perceive Affordances,” Frontiers in Psychology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Lui Unterrassner, Thomas A. Wyss, Diana Wotruba, Vladeta Ajdacic-Gross, Helene Haker, and Wulf Rössler, “Psychotic-Like Experiences at the Healthy End of the Psychosis Continuum,” Frontiers in Psychology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Yansong Li, Guoliang Chen, Weiyan Ding, Lei Zhang, Hong Cui, and Zhongdong Jiang, “Neurophysiological Evidence of Compensatory Brain Mechanisms Underlying Attentional-Related Processes in Symptomatically Remitted Patients with Schizophrenia,” Frontiers in Psychology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Shihao Wu, Huiling Wang, Cheng Chen, Jilin Zou, Huan Huang, Peifu Li, Yilin Zhao, Qizhong Xu, Liang Zhang, Hesheng Wang, Sanjib Pandit, Subodh Dahal, Jun Chen, Yuan Zhou, Tianzi Jiang, and Gaohua Wang, “Task Performance Modulates Functional Connectivity Involving the Dorsolateral Prefrontal Cortex in Patients with Schizophrenia,” Frontiers in Psychology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • François Montastruc, Justine Benevent, Anthony Touafchia, Leila Chebane, Mélanie Araujo, Emmanuelle Guitton-Bondon, Geneviève Durrieu, Christophe Arbus, Laurent Schmitt, Bernard Begaud, and Jean-Louis Montastruc, “Atropinic (anticholinergic) burden in antipsychotic-treated patients,” Fundamental & Clinical Pharmacology, 2017. View at Publisher · View at Google Scholar
  • Jennifer L. Neary, Stephanie M. Perez, Kara Peterson, Daniel J. Lodge, and Melanie A. Carless, “Comparative analysis of MBD-seq and MeDIP-seq and estimation of gene expression changes in a rodent model of schizophrenia,” Genomics, 2017. View at Publisher · View at Google Scholar
  • Yi-Hui Wu, Chih-Jen Wang, Cheng-Hao Hung, Liang-Yu Chen, Ming-Hsien Lin, Pei-Ning Wang, and Liang-Kung Chen, “Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan,” Geriatrics & Gerontology International, vol. 17, pp. 57–64, 2017. View at Publisher · View at Google Scholar
  • Manuel Gonçalves-Pereira, Eduardo González-Fraile, Borja Santos-Zorrozúa, Manuel Martín-Carrasco, Paola Fernández-Catalina, Ana I. Domínguez-Panchón, Paula Muñoz-Hermoso, and Javier Ballesteros, “Assessment of the consequences of caregiving in psychosis: a psychometric comparison of the Zarit Burden Interview (ZBI) and the Involvement Evaluation Questionnaire (IEQ),” Health and Quality of Life Outcomes, vol. 15, no. 1, 2017. View at Publisher · View at Google Scholar
  • Tobias Wensing, Edna C. Cieslik, Veronika I. Müller, Felix Hoffstaedter, Simon B. Eickhoff, and Thomas Nickl-Jockschat, “Neural correlates of formal thought disorder: An activation likelihood estimation meta-analysis,” Human Brain Mapping, 2017. View at Publisher · View at Google Scholar
  • Amy Blank Wilson, Kathleen Farkas, Natalie Bonfine, and Janelle Duda-Banwar, “Interventions That Target Criminogenic Needs for Justice-Involved Persons With Serious Mental Illnesses,” International Journal of Offender Therapy and Comparative Criminology, pp. 0306624X1769558, 2017. View at Publisher · View at Google Scholar
  • Fatin G Ashoor, and Intisar AG Khudhur, “Assessment of Needs: Differences between male and female patients with schizophrenia needs in psychiatric hospitals in Baghdad city,” International Journal of Social Psychiatry, pp. 002076401772577, 2017. View at Publisher · View at Google Scholar
  • Ali Soltaninejad, Ernst von Kardorff, Mohammad Kamali, and Mahin Eslami Shahrbabaki, “Development and Validation of a Questionnaire to Measure Quality of Life in Caregivers of Patients with Schizophrenia and Affective Disorders (SAC-QoL),” Iranian Journal of Psychiatry and Behavioral Sciences, vol. InPress, no. InPress, 2017. View at Publisher · View at Google Scholar
  • Peter Tonn, Silja Christin Reuter, Isabelle Kuchler, Britta Reinke, Lena Hinkelmann, Saskia Stöckigt, Hanna Siemoneit, and Nina Schulze, “Development of a Questionnaire to Measure the Attitudes of Laypeople, Physicians, and Psychotherapists Toward Telemedicine in Mental Health,” JMIR Mental Health, vol. 4, no. 4, pp. e39, 2017. View at Publisher · View at Google Scholar
  • Sarah Lytle, Molly McVoy, and Martha Sajatovic, “Long-Acting Injectable Antipsychotics in Children and Adolescents,” Journal of Child and Adolescent Psychopharmacology, 2017. View at Publisher · View at Google Scholar
  • Lisa Whitehead, Elisabeth Jacob, Amanda Towell, Ma'en Abu-qamar, and Amanda Cole-Heath, “The role of the family in supporting the self-management of chronic conditions: A qualitative systematic review,” Journal of Clinical Nursing, 2017. View at Publisher · View at Google Scholar
  • Hans Rittmannsberger, Jan Rosenleitner, Gertraud Malsiner-Walli, Regina Werl, Barbara Rittmannsberger, and Kurosch Yazdi, “Treatment Duration With Long-Acting Injectable Antipsychotics After In-hospital Initiation,” Journal of Clinical Psychopharmacology, vol. 37, no. 2, pp. 250–254, 2017. View at Publisher · View at Google Scholar
  • Emilia Matera, Lucia Margari, Vincenzo Ostilio Palmieri, Giuseppina Zagaria, Roberto Palumbi, and Francesco Margari, “Risperidone and Cardiometabolic Risk in Children and Adolescents,” Journal of Clinical Psychopharmacology, vol. 37, no. 3, pp. 302–309, 2017. View at Publisher · View at Google Scholar
  • Vanessa Cavalcante da Silva, Allan Chiaratti de Oliveira, and Vânia D’Almeida, “Homocysteine and Psychiatric Disorders,” Journal of Inborn Errors of Metabolism and Screening, vol. 5, pp. 232640981770147, 2017. View at Publisher · View at Google Scholar
  • Selwyn Stanley, Sujeetha Balakrishnan, and S. Ilangovan, “Psychological distress, perceived burden and quality of life in caregivers of persons with schizophrenia,” Journal of Mental Health, vol. 26, no. 2, pp. 134–141, 2017. View at Publisher · View at Google Scholar
  • Elizabeth A. Klingaman, Julie M. Mccarthy, Elana K. Schwartz, Philip R. Gehrman, and Melanie E. Bennett, “Targets for the Treatment of Insomnia in Veterans With Serious Mental Illness,” Journal of Psychiatric Practice, vol. 23, no. 4, pp. 270–280, 2017. View at Publisher · View at Google Scholar
  • Keita Fukuhara, Yasuhiro Ogawa, Hiroyuki Tanaka, Yuma Nagata, Saiji Nishida, Daisuke Haga, and Takashi Nishikawa, “Impaired Interpretation of Others’ Behavior is Associated with Difficulties in Recognizing Pragmatic Language in Patients with Schizophrenia,” Journal of Psycholinguistic Research, 2017. View at Publisher · View at Google Scholar
  • E. Valladier, D. Willard, L. Romo, Y. Hodé, and Y. Morvan, “La dépression chez les proches de patients souffrants de schizophrénie : effets longitudinaux sur 8 mois du programme ProFamille,” L'Encéphale, 2017. View at Publisher · View at Google Scholar
  • Kimberly Case, Yi Guo, Sara Jo Nixon, Keith Muller, Tianyao Huo, Robert Prather, Heather Morris, Dena Stoner, and Elizabeth Shenkman, “Exploring the Role of Executive Functioning Capacity in Patient Activation and Health Outcomes Among Medicaid Members With Multiple Comorbidities,” Medical Care Research and Review, pp. 107755871770941, 2017. View at Publisher · View at Google Scholar
  • Fen Pan, Jun-Yuan Wang, Yi Xu, and Man-Li Huang, “Abnormal parietal encephalomalacia associated with schizophrenia,” Medicine, vol. 96, no. 10, pp. e6310, 2017. View at Publisher · View at Google Scholar
  • Buranee Kanchanatawan, Sunee Sirivichayakul, Supaksorn Thika, Kiat Ruxrungtham, André F. Carvalho, Michel Geffard, George Anderson, Cristiano Noto, Rada Ivanova, and Michael Maes, “Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway,” Metabolic Brain Disease, 2017. View at Publisher · View at Google Scholar
  • A E Lyall, O Pasternak, D G Robinson, D Newell, J W Trampush, J A Gallego, M Fava, A K Malhotra, K H Karlsgodt, M Kubicki, and P R Szeszko, “Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning,” Molecular Psychiatry, 2017. View at Publisher · View at Google Scholar
  • Meng-Lin Li, Yelena Gulchina, Sarah A. Monaco, Bo Xing, Brielle R. Ferguson, Yan-Chun Li, Feng Li, Xi-Quan Hu, and Wen-Jun Gao, “Juvenile treatment with a novel mGluR2 agonist/mGluR3 antagonist compound, LY395756, reverses learning deficits and cognitive flexibility impairments in adults in a neurodevelopmental model of schizophrenia,” Neurobiology of Learning and Memory, vol. 140, pp. 52–61, 2017. View at Publisher · View at Google Scholar
  • Megan A. Boudewyn, Cameron S. Carter, Debra L. Long, Matthew J. Traxler, Tyler A. Lesh, George R. Mangun, and Tamara Y. Swaab, “Language Context Processing Deficits in Schizophrenia: The Role of Attentional Engagement,” Neuropsychologia, 2017. View at Publisher · View at Google Scholar
  • Shivangi Patel, Dilip Sharma, Kiran Kalia, and Vinod Tiwari, “Crosstalk between Endoplasmic Reticulum Stress and Oxidative Stress in Schizophrenia: The Dawn of New Therapeutic Approaches,” Neuroscience & Biobehavioral Reviews, 2017. View at Publisher · View at Google Scholar
  • Błażej Misiak, Maja Krefft, Tomasz Bielawski, Ahmed A. Moustafa, Maria M. Sąsiadek, and Dorota Frydecka, “Toward a unified theory of childhood trauma and psychosis: a comprehensive review of epidemiological, clinical, neuropsychological and biological findings,” Neuroscience & Biobehavioral Reviews, 2017. View at Publisher · View at Google Scholar
  • Xin Zhao, Lin Tian, Jun Yan, Weihua Yue, Hao Yan, and Dai Zhang, “Abnormal Rich-Club Organization Associated with Compromised Cognitive Function in Patients with Schizophrenia and Their Unaffected Parents,” Neuroscience Bulletin, vol. 33, no. 4, pp. 445–454, 2017. View at Publisher · View at Google Scholar
  • Ning Fan, Yunlong Tan, Fude Yang, Li Tian, Song Chen, Jia Li, Zhiren Wang, and Xiangyang Zhang, “Effect of Risperidone on Serum Homocysteine Levels in First-episode, Drug-naïve Patients with Schizophrenia,” Neuroscience Letters, 2017. View at Publisher · View at Google Scholar
  • Suzan Kudlek Mikulic, Alma Mihaljevic-Peles, Marina Sagud, Maja Bajs Janovic, Lana Ganoci, Jasmina Grubisin, Martina Kuzman Rojnic, Bjanka Vuksan Cusa, Zoran Bradaš, and Nada Božina, “Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study,” Nordic Journal of Psychiatry, vol. 71, no. 7, pp. 513–520, 2017. View at Publisher · View at Google Scholar
  • Maria Afzelius, Margareta Östman, Maria Råstam, and Gisela Priebe, “Parents in adult psychiatric care and their children: a call for more interagency collaboration with social services and child and adolescent psychiatry,” Nordic Journal of Psychiatry, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  • Doreen Mucheru, Mary-Claire Hanlon, Linda Campbell, Mark McEvoy, and Lesley MacDonald-Wicks, “Social Dysfunction and Diet Outcomes in People with Psychosis,” Nutrients, vol. 9, no. 1, pp. 80, 2017. View at Publisher · View at Google Scholar
  • Youssef Kouidrat, Ali Amad, Brendon Stubbs, Suzan Moore, and Fiona Gaughran, “Surgical Management of Obesity Among People with Schizophrenia and Bipolar Disorder: a Systematic Review of Outcomes and Recommendations for Future Research,” Obesity Surgery, 2017. View at Publisher · View at Google Scholar
  • Mark Pennington, and Paul McCrone, “The Cost of Relapse in Schizophrenia,” PharmacoEconomics, 2017. View at Publisher · View at Google Scholar
  • Yu Yu, Zi-wei Liu, Bing-wei Tang, Mei Zhao, Xi-guang Liu, and Shui-yuan Xiao, “Reported family burden of schizophrenia patients in rural China,” Plos One, vol. 12, no. 6, pp. e0179425, 2017. View at Publisher · View at Google Scholar
  • J. Adam Noah, Swethasri Dravida, Xian Zhang, Shaul Yahil, and Joy Hirsch, “Neural correlates of conflict between gestures and words: A domain-specific role for a temporal-parietal complex,” Plos One, vol. 12, no. 3, pp. e0173525, 2017. View at Publisher · View at Google Scholar
  • Esther Setién-Suero, Karl Neergaard, Mariluz Ramírez-Bonilla, Patricia Correa-Ghisays, Lourdes Fañanás, Benedicto Crespo-Facorro, and Rosa Ayesa-Arriola, “Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences,” Plos One, vol. 12, no. 8, pp. e0183613, 2017. View at Publisher · View at Google Scholar
  • Lorna Farrelly, Maria Victoria Rosato-Siri, Melanie Föcking, Martin Codagnone, Analia Reines, Patrick Dicker, Kieran Wynne, Michael Farrell, Mary Cannon, Gerard Cagney, Juana Maria Pasquini, and David R. Cotter, “The Effects of Prenatal Iron Deficiency and Risperidone Treatment on the Rat Frontal Cortex:  A Proteomic Analysis,” Proteomics, vol. 17, no. 17-18, pp. 1600407, 2017. View at Publisher · View at Google Scholar
  • Gerard Anmella Diaz, Maria Cristina Costanzo, María Elena Rosas Meneses, and Miguel Bernardo Arroyo, “Una revisión de los trastornos del sueño en la esquizofrenia,” Psiquiatría Biológica, 2017. View at Publisher · View at Google Scholar
  • Mark Savill, Stavros Orfanos, Richard Bentall, Ulrich Reininghaus, Til Wykes, and Stefan Priebe, “The impact of gender on treatment effectiveness of body psychotherapy for negative symptoms of schizophrenia: A secondary analysis of the NESS trial data,” Psychiatry Research, vol. 247, pp. 73–78, 2017. View at Publisher · View at Google Scholar
  • Chiara Galletti, Enrico Paolini, Alfonso Tortorella, and Michael T. Compton, “Auditory and Non-Auditory Hallucinations in First-Episode Psychosis: Differential Associations with Diverse Clinical Features,” Psychiatry Research, 2017. View at Publisher · View at Google Scholar
  • Haylee Danaher, Kelly Allott, Eóin Killackey, Robert Hester, and Sue Cotton, “An Examination of Sex Differences in Neurocognition and Social Cognition in First-Episode Psychosis,” Psychiatry Research, 2017. View at Publisher · View at Google Scholar
  • Ana Catalan, Virxina Angosto, Aida Díaz, Cristina Valverde, Maider Gonzalez de Artaza, Eva Sesma, Claudio Maruottolo, Iñaki Galletero, Sonia Bustamante, Amaia Bilbao, Jim van Os, and Miguel Angel Gonzalez-Torres, “Relation between psychotic symptoms, parental care and childhood trauma in severe mental disorders,” Psychiatry Research, 2017. View at Publisher · View at Google Scholar
  • C. Wang, and Y. Zhang, “Season of Birth and Schizophrenia: Evidence from China,” Psychiatry Research, 2017. View at Publisher · View at Google Scholar
  • Esin Evren Kilicaslan, Aslı Tuğba Esen, Meltem Izci Kasal, Erdal Özelçi, Murat Boysan, and Mustafa Güleç, “Childhood Trauma, Depression, and Sleep Quality and their Association with Psychotic Symptoms and Suicidality in Schizophrenia,” Psychiatry Research, 2017. View at Publisher · View at Google Scholar
  • Sophie Béland, and Martin Lepage, “The relative contributions of social cognition and self-reflectiveness to clinical insight in enduring schizophrenia,” Psychiatry Research, 2017. View at Publisher · View at Google Scholar
  • Siri Helle, Else-Marie Løberg, Rolf Gjestad, Ashley M. Schnakenberg Martin, and Paul H. Lysaker, “The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognition,” Psychiatry Research, 2017. View at Publisher · View at Google Scholar
  • Xing-jie Wu, Ling-Li Zeng, Hui Shen, Lin Yuan, Jian Qin, Peng Zhang, and De-wen Hu, “Functional network connectivity alterations in schizophrenia and depression,” Psychiatry Research: Neuroimaging, 2017. View at Publisher · View at Google Scholar
  • Melissa LaVan, Helen LaVan, and William M. Marty Martin, “Antecedents, Behaviours, and Court Case Characteristics and Their Effects on Case Outcomes in Litigation for Persons with Schizophrenia,” Psychiatry, Psychology and Law, pp. 1–22, 2017. View at Publisher · View at Google Scholar
  • Gabrielle Le Geyt, Yvonne Awenat, Sara Tai, and Gillian Haddock, “Personal Accounts of Discontinuing Neuroleptic Medication for Psychosis,” Qualitative Health Research, vol. 27, no. 4, pp. 559–572, 2017. View at Publisher · View at Google Scholar
  • Miguel Bernardo, Fernando Cañas, Berta Herrera, and Marta García Dorado, “Adherence predicts symptomatic and psychosocial remission in schizophrenia: Naturalistic study of patient integration in the community,” Revista de Psiquiatría y Salud Mental (English Edition), 2017. View at Publisher · View at Google Scholar
  • P. Brunault, A. Bray, C. Rerolle, S. Cognet, P. Gaillard, and W. El-Hage, “Différences d’accès à Internet et de recherche d’informations en santé via Internet selon le trouble psychiatrique,” Revue d'Épidémiologie et de Santé Publique, 2017. View at Publisher · View at Google Scholar
  • Eugene YH Yeung, Soojin Chun, Alan Douglass, and Timothy E Lau, “Effect of atypical antipsychotics on body weight in geriatric psychiatric inpatients,” SAGE Open Medicine, vol. 5, pp. 205031211770871, 2017. View at Publisher · View at Google Scholar
  • Bharti Morar, Johanna C. Badcock, Michael Phillips, Osvaldo P. Almeida, and Assen Jablensky, “The longevity gene Klotho is differentially associated with cognition in subtypes of schizophrenia,” Schizophrenia Research, 2017. View at Publisher · View at Google Scholar
  • Anuradha Sharma, Heinrich Sauer, Holger Hill, Claudia Kaufmann, Stephan Bender, and Matthias Weisbrod, “Abnormal N400 Semantic Priming Effect May Reflect Psychopathological Processes in Schizophrenia: A Twin Study,” Schizophrenia Research and Treatment, vol. 2017, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  • Julia Ermel, Cameron S. Carter, James M. Gold, Angus W. MacDonald, J. Daniel Ragland, Steven M. Silverstein, Milton E. Strauss, and Deanna M. Barch, “Self versus informant reports on the specific levels of functioning scale: Relationships to depression and cognition in schizophrenia and schizoaffective disorder,” Schizophrenia Research: Cognition, vol. 9, pp. 1–7, 2017. View at Publisher · View at Google Scholar
  • Laurence J. Howe, A. Mesut Erzurumluoglu, George Davey Smith, Santiago Rodriguez, and Evie Stergiakouli, “Y Chromosome, Mitochondrial DNA and Childhood Behavioural Traits,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Kuo-Hsuan Chung, Hung-Yi Chiou, and Yi-Hua Chen, “Associations between serum homocysteine levels and anxiety and depression among children and adolescents in Taiwan,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • S. M. Cotton, M. Lambert, B. G. Schimmelmann, K. Filia, V. Rayner, L. Hides, D. L. Foley, A. Ratheesh, A. Watson, P. Rodger, P. D. McGorry, and P. Conus, “Predictors of functional status at service entry and discharge among young people with first episode psychosis,” Social Psychiatry and Psychiatric Epidemiology, 2017. View at Publisher · View at Google Scholar
  • Brea L. Perry, Emma Frieh, and Eric R. Wright, “Therapeutic Social Control of People with Serious Mental Illness: An Empirical Verification and Extension of Theory,” Society and Mental Health, pp. 215686931772589, 2017. View at Publisher · View at Google Scholar
  • Qian Li, Yun-Ai Su, Yu-Tao Xiang, Liang Shu, Xin Yu, Gabor S. Ungvari, Stephen J. Seiner, Helen F.K. Chiu, Yu-Ping Ning, Gao-Hua Wang, Ke-Rang Zhang, Tao Li, Li-Zhong Sun, Jian-Guo Shi, Xian-Sheng Chen, Qi-Yi Mei, Ke-Qing Li, and Tian-Mei Si, “Electroconvulsive Therapy in Schizophrenia in China,” The Journal of ECT, vol. 33, no. 2, pp. 138–142, 2017. View at Publisher · View at Google Scholar
  • Mounir Ouzir, Jean Michel Azorin, Nadia Correard, Sara-Nora Elissalde, Romain Padovani, Christophe Lançon, Omar Battas, and Driss Boussaoud, “Tobacco status, impulsivity, and the five-factor of the PANSS in paranoid schizophrenia,” The Journal of Forensic Psychiatry & Psychology, pp. 1–15, 2017. View at Publisher · View at Google Scholar